Company Search:
Advanced Search
Sponsored Links
Lonza Group AG Company Snapshot
Lonza Group AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lonza Group AG with three other pharmaceutical manufacturers in Europe: H. Lundbeck A/S of DENMARK (2020 sales of 17.67 billion Danish Kroner [US$2.77 billion] of which 100% was Pharmaceuticals), Hikma Pharmaceuticals PLC of UNITED KINGDOM (£1.81 billion [US$2.50 billion] of which 42% was Injectable Pharmaceuticals), and Stada Arzneimittel AG which is based in GERMANY (3.01 billion Euros [US$3.50 billion] of which 55% was Generics).

Sales Analysis. During the second quarter of 2021, sales at Lonza Group AG totalled 2.54 billion Swiss Francs. This is a drop of 17.3% from the 3.07 billion Swiss Francs in sales at the company during the second quarter in 2020. During the year ended December of 2020, sales at Lonza Group AG were 4.51 billion Swiss Francs (US$4.91 billion). This is a sharp decrease of 23.9% versus 2019, when the company's sales were 5.92 billion Swiss Francs. Contributing to the drop in overall sales was the 40.0% decline in Eliminations, from 60.00 million Swiss Francs to 36.00 million Swiss Francs. There were also decreases in sales in Specialty Ingredients (down 0.9% to 1.68 billion Swiss Francs) . However, these declines were partially offset by the increase in sales of Pharma&biotech (up 7.3% to 4.47 billion Swiss Francs) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lonza Group AG
  Stock Performance Chart for Lonza Group AG
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 755.00
(Figures in Swiss Francs)
1 Week 4.6%   13 Weeks 1.7%  
4 Weeks 7.0%   52 Weeks 31.3%  
Lonza Group AG Key Data:
  Ticker: LONN Country: Switzerland
  Exchanges: FRA GVA OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 4,508,000,000
(Year Ending Jan 2021).
Employees: 16,540
  Currency: Swiss Francs Market Cap: 56,083,719,360
  Fiscal Yr Ends: December Shares Outstanding: 74,283,072
  Share Type: Namenaktie Closely Held Shares: 72,235
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.